Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022 (vol 27, 2200250, 2022)

被引：0
|
作者：
Castillo, Suarez
机构：
来源：
EUROSURVEILLANCE | 2022年 / 27卷 / 17期
关键词：
D O I：
10.2807/1560-7917.ES.2022.27.17.220428c
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：1
相关论文
共 23 条
  • [1] Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
    Castillo, Milena Suarez
    Khaoua, Hamid
    Courtejoie, Noemie
    EUROSURVEILLANCE, 2022, 27 (16)
  • [2] Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes
    Buchan, Sarah A.
    Chung, Hannah
    Brown, Kevin A.
    Austin, Peter C.
    Fell, Deshayne B.
    Gubbay, Jonathan B.
    Nasreen, Sharifa
    Schwartz, Kevin L.
    Sundaram, Maria E.
    Tadrous, Mina
    Wilson, Kumanan
    Wilson, Sarah E.
    Kwong, Jeffrey C.
    JAMA NETWORK OPEN, 2022, 5 (09) : E2232760
  • [3] Temporal, age, and geographical variation in vaccine efficacy against infection by the Delta and Omicron variants in the community in France, December 2021 to March 2022
    Blanquart, Francois
    Abad, Clemence
    Ambroise, Joevin
    Bernard, Mathieu
    Debarre, Florence
    Giannoli, Jean-Marc
    Rey, Thomas
    Vieillefond, Vincent
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 133 : 89 - 96
  • [4] COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022
    Braeye, Toon
    van Loenhout, Joris A. F.
    Brondeel, Ruben
    Stouten, Veerle
    Hubin, Pierre
    Billuart, Matthieu
    Chung, Pui Yan Jenny
    Vandromme, Mathil
    Wyndham-Thomas, Chloe
    Blot, Koen
    Catteau, Lucy
    EUROSURVEILLANCE, 2023, 28 (26)
  • [5] Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France
    Tchuem, Cynthia Raissa Tamandjou
    Auvigne, Vincent
    Vaux, Sophie
    Montagnat, Charline
    Paireau, Juliette
    Besnard, Stephanie Monnier
    Gabet, Amelie
    Benhajkassen, Nabil
    Le Strat, Yann
    Chatelet, Isabelle Parent Du
    Levy-Bruhl, Daniel
    VACCINE, 2023, 41 (13) : 2280 - 2288
  • [6] Severe hospital events following symptomatic infection with Sars-CoV-2 Omicron and Delta variants in France, December 2021-January 2022: A retrospective, population-based, matched cohort study
    Auvigne, Vincent
    Vaux, Sophie
    Le Strat, Yann
    Schaeffer, Justine
    Fournier, Lucie
    Tamandjou, Cynthia
    Montagnat, Charline
    Coignard, Bruno
    Levy-Bruhl, Daniel
    du Chatelet, Isabelle Parent
    ECLINICALMEDICINE, 2022, 48
  • [7] Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022
    Piralla, Antonio
    Mojoli, Francesco
    Pellegrinelli, Laura
    Ceriotti, Ferruccio
    Valzano, Antonia
    Grasselli, Giacomo
    Gismondo, Maria Rita
    Micheli, Valeria
    Castelli, Antonio
    Farina, Claudio
    Arosio, Marco
    Lorini, Ferdinando Luca
    Fanti, Diana
    Busni, Andrea
    Laratta, Matteo
    Maggi, Fabrizio
    Novazzi, Federica
    Cabrini, Luca
    Callegaro, Anna Paola
    Keim, Roberto
    Remuzzi, Giuseppe
    Cavallero, Annalisa
    Malandrin, Sergio Maria Ivano
    Rona, Roberto
    Giardina, Federica
    Ferrari, Guglielmo
    Zavaglio, Federica
    D'angelo, Piera
    Galli, Cristina
    Bubba, Laura
    Binda, Sandro
    Oggioni, Massimo
    Renteria, Sara Colonia Uceda
    Bono, Patrizia
    Baj, Andreina
    Ferrante, Francesca Drago
    Guarneri, Davide
    Tonelli, Marco
    Napolitano, Gavino
    Nava, Alice
    Romeo, Lorenzo
    Nicolini, Elena
    Valaperta, Rea
    Varisano, Ludovica
    Mele, Caterina
    Liguori, Lucia
    Raggi, Monica
    Mongodi, Silvia
    Pagani, Michele
    Severgnini, Paolo
    RESPIRATORY MEDICINE AND RESEARCH, 2023, 83
  • [8] COVID-19 vaccines effectiveness against symptomatic disease and severe outcomes, 2021-2022: a test-negative case-control study
    Brazete, C.
    Brazete, J.
    Alves, F.
    Aguiar, A.
    Goncalves, A. M.
    Cardoso, M.
    Sa, L.
    Goncalves, E.
    Pinto, M.
    Duarte, R.
    PUBLIC HEALTH, 2023, 218 : 84 - 91
  • [9] Protection of Two and Three mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized With COVID-19-VISION Network, August 2021 to March 2022
    DeSilva, Malini B.
    Mitchell, Patrick K.
    Klein, Nicola P.
    Dixon, Brian E.
    Tenforde, Mark W.
    Thompson, Mark G.
    Naleway, Allison L.
    Grannis, Shaun J.
    Ong, Toan C.
    Natarajan, Karthik
    Reese, Sarah E.
    Zerbo, Ousseny
    Kharbanda, Anupam B.
    Patel, Palak
    Stenehjem, Edward
    Raiyani, Chandni
    Irving, Stephanie A.
    Fadel, William F.
    Rao, Suchitra
    Han, Jungmi
    Reynolds, Sue
    Davis, Jonathan M.
    Lewis, Ned
    McEvoy, Charlene
    Dickerson, Monica
    Dascomb, Kristin
    Valvi, Nimish R.
    Barron, Michelle A.
    Goddard, Kristin
    Vazquez-Benitez, Gabriela
    Grisel, Nancy
    Mamawala, Mufaddal
    Embi, Peter J.
    Fireman, Bruce
    Essien, Inih J.
    Griggs, Eric P.
    Arndorfer, Julie
    Gaglani, Manjusha
    JOURNAL OF INFECTIOUS DISEASES, 2023, 227 (08): : 961 - 969
  • [10] Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities- surveillance results from southern Sweden, July 2021 to January 2022
    Kahn, Fredrik
    Bonander, Carl
    Moghaddassi, Mahnaz
    Rasmussen, Magnus
    Malmqvist, Ulf
    Inghammar, Malin
    Bjork, Jonas
    EUROSURVEILLANCE, 2022, 27 (09)
123